A Cohort Study of the Prognostic Impact of Exon-16 EZH2 Mutations in a Mexican-Mestizo Population of Patients with Diffuse Large B-Cell Lymphoma

Background: Novel prognostic factors in patients with diffuse large B-cell lymphoma (DLBCL) are required in the era of Rituximab. Objective: The objective of the study was to study the prognostic impact of exon-16 enhancer-of-zeste homolog-2 (EZH2) mutations in patients with DLBCL. Methods: In a coh...

Full description

Bibliographic Details
Main Authors: Luis F. Oñate-Ocaña, Mayra Ponce-Martínez, Lucia Taja-Chayeb, Olga Gutiérrez-Hernández, Alejandro Avilés-Salas, David Cantú-de-León, Alfonso Dueñas-González, Myrna Candelaria-Hernández
Format: Article
Language:English
Published: Permanyer 2021-01-01
Series:Revista de Investigación Clínica
Subjects:
Online Access:https://www.clinicalandtranslationalinvestigation.com/frame_esp.php?id=377